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Abstract
The development and availability is
described of new, user friendly software,
the Maternal and Child Health Smoking
Attributable Mortality, Morbidity and
Economic Costs (MCHSAMMEC), that
will allow states and other entities to esti-
mate pregnancy related, smoking attrib-
utable costs for their population. The
methodology underlying the MCHSAM-
MEC software, including calculations
used in the prevalence based analysis of
smoking attributable mortality and costs
of infant neonatal care, are described,
along with design and data management
features and possible applications of the
software for policy and program develop-
ment at various levels of the health care
system.
(Tobacco Control 2000;9(Suppl III):iii12–iii15)
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It is clear that, for the general population in the
USA, there is excess morbidity and mortality
attributable to smoking. Unfortunately,
although considerable progress has been made
in measuring the health care costs of smoking
that occur in the long run, less is known about
the smoking attributable costs that occur when
pregnant women smoke. The causal associa-
tion between maternal smoking and maternal
morbidity, infant mortality, and infant morbid-
ity is well established. In 1997, 11% to 23.9%
of pregnant women in the USA reported
smoking throughout their pregnancy.1
A microcomputer software program (Smok-
ing Attributable Mortality Morbidity and Eco-
nomic Costs, or SAMMEC) was developed
previously by the Centers for Disease Control
and Prevention (CDC) to generate national
and state estimates of the cost impact of smok-
ing attributable disease.2 These impacts are
expressed as smoking attributable mortality,
years of potential life lost, direct health care
costs, and indirect costs. SAMMEC-generated
estimates are often used to support tobacco
control legislation and policy at the state and
national level.
EVorts are currently under way to develop
SAMMEC 4.0 for each of three population
groups: adults (ages 18 and over), neonates
(newborns), and children (ages 0–12 years).
The current version of SAMMEC (3.0) does
not include estimates of the costs related to
smoking during pregnancy. To address this
important source of smoking related
expenditure, construction of neonatal and
childhood components was undertaken as a
part of SAMMEC 4.0. In combination, they
will form the Maternal and Child Health
SAMMEC module (MCHSAMMEC), a
stand alone adjunct to SAMMEC 4.0. This
user friendly software will allow states and
other entities to estimate pregnancy related
smoking attributable costs in their population.
Methods
MCHSAMMEC, as now constructed, per-
forms a prevalence based analysis of smoking
attributable mortality and costs of infant
neonatal care. Calculation of each of the
impact measures relies on the estimate of a
smoking attributable fraction (SAF) derived
from either a relative risk approach or a multi-
variate analysis. The use of multivariate analy-
sis to derive the SAF for direct health care costs
diVers from the attributable risk approach used
in the original SAMMEC.
SAF DERIVATION
The SAF, which is the proportion of cases or
deaths that can be regarded as causally linked
to cigarette smoking, also represents the
proportion by which the outcome would be
reduced if exposure to cigarette smoking was
eliminated. In our estimates of neonatal costs,
or SAFs, exposure includes only active
maternal smoking throughout pregnancy.
Using responses to the Pregnancy Risk Assess-
ment Monitoring System (PRAMS) question
on smoking status during the last three months
of pregnancy, and self reports of smoking
status during pregnancy from the birth certifi-
cate, women were classified as smokers if they
indicated that they were still smoking during
the third trimester of pregnancy or if they used
tobacco during pregnancy. As now con-
structed, the outcomes in MCHSAMMEC
include infant mortality, percentage of infants
with low birth weight, birth weight in grams,
probability of admission to the neonatal inten-
sive care unit (NICU), number of infant hospi-
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tal days, and total neonatal health care costs.
Neonatal health care costs are measured as the
dollars paid for all health care services
provided to a neonate in the hospital setting.
Maternal complications associated with smok-
ing during pregnancy also have the potential to
increase health care costs. Previous estimates
of these costs used the attributable risk
approach and have been published elsewhere.3
In our multivariate analysis using PRAMS
data, however, we found no eVect of active
smoking on health care resources used by the
mother and hence, these costs are not included
in MCHSAMMEC. Indirect costs (for
example, lost wages) are also not included at
this time.
IMPACT MEASURES: INFANT MORTALITY
Traditionally, derivation of an SAF is based on
the following formula, which uses relative risk
estimates for smoking related conditions and
the prevalence of smoking in the population
(here, a pregnant population):
SAF = {[p0 + p1(RR1)]− 1}/[p0 + p1(RR1)]
where: p0 = percentage of pregnant current
nonsmokers; p1 = percentage of pregnant
current smokers; and RR1 = relative risk of
outcome for pregnant current smokers relative
to pregnant current non-smokers.
For infant mortality, the SAF is derived from
pediatric conditions (for example, sudden
infant death syndrome) resulting in infant
death (less than 1 year of age). Again, in
estimating these deaths, smoking prevalence
refers only to active maternal smoking. For the
selected infant conditions, smoking attribut-
able infant mortality is calculated as follows:
smoking attributable infant deaths = total
infant deaths × SAF
The relative risks for infant mortality due to
smoking during pregnancy used in deriving
this SAF are currently being updated by a
review of the literature and estimated by meta-
analysis where appropriate.4 Methodological
details regarding the updated relative risks will
be documented and appropriately referenced
in the discussion portion of the software (see
Design Features section).
IMPACT MEASURES: SMOKING ATTRIBUTABLE
DIRECT HEALTH CARE COSTS
The attributable risk approach described above
also applies SAFs to corresponding health care
expenditures to derive smoking attributable
health care costs.2 This approach, however,
does not account for the complex interactions
of factors that determine actual costs incurred
by individual smokers (for example, smoker’s
race, age) or isolate the eVects of smoking from
other factors, such as alcohol abuse. For exam-
ple, we do not have estimates of how changing
smoking behaviour might change other risk
behaviours during pregnancy. Furthermore,
we do not know how these behaviours aVect
the outcomes of interest, birth weight,
probability of NICU admission, and infant
length of stay either individually or in
combination. This approach also does not
allow for diVerences in the costs of a given out-
come such as low birth weight for infants of
smokers and non-smokers. The multivariate
approach corrects for some of these problems
and is used here to derive smoking attributable
neonatal health care costs for MCHSAM-
MEC. It is also being used to update the over-
all SAMMEC 4.0 model and software.
Regression models were used to estimate the
relation of maternal smoking to probability of
NICU admission and to length of stay for the
infant.5 Based on these regressions, the








where I indexes individuals: wi is the
observation weight, xi is the vector of
independent variable values for individual I; bp
is the estimated vector of coeYcients for the
probability equation; and be is the estimated
coeYcient vector for the log expense equation.
The values of the smoking variable(s) have
been set to their actual value in x’ and to zero in
xi
*.
The numerator of this expression is the
aggregate smoking attributable birth weight in
grams, probability of admission to the NICU,
and number of infant hospital days (for exam-
ple, infant length of stay), depending on the
coeYcients used. For example, it is the
diVerence in expected birth weight given actual
in utero smoke exposure and the expected
birth weight given no exposure. The actual
dollar value of the expense SAF is based on all
inpatient health care expenses per night
incurred over the infant’s full stay. A weighted
average of the NICU expenses per night and
the non-NICU expenses per night is used.5
The regressions underlying the SAFs were
estimated with 1995 data from the PRAMS, an
ongoing surveillance project of the CDC. In
1995, 13 states (Alabama, Alaska, California,
Florida, Georgia, Indiana, Maine, Michigan,
New York (excluding New York City),
Oklahoma, South Carolina, Washington, and
West Virginia) and the District of Columbia
participated in PRAMS. The data are
generated so as to be representative of all live
births in each state although there is
state-specific oversampling of certain low
income and racial groups. Sample weights are
provided with the data. PRAMS data on
approximately 25 000 live births in the partici-
pating states and the District of Columbia were
used.
In addition to PRAMS, a secondary data set
available to the CDC from the MedStat
Corporation is used to estimate the average
number of NICU nights incurred by newborns
and to attach average health care expenses to
NICU and non-NICU nursery nights. The
data set is a subset of birth records drawn from
the MarketScan© database of commercially
insured health care claims. It contains data
pooled from Medstat’s employer/payer cus-
tomers. The database contains detailed
information on services administered and pay-
ments made for each service, including
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deductibles and co-payments, for approxi-
mately 17 000 deliveries from 1995. The data
are not representative of any particular
geographic area.
For a full discussion of the regression
techniques used to estimate the above
coeYcients and the economic interpretation of
the smoking attributable cost estimates, the
user should refer to the appropriate discussion
portions of the software as described in the
Disease Impact section of this article.
Users of MCHSAMMEC should recognise
the limitations of the actual dollar values
generated by the software. Since the data and
analysis do not include maternal or indirect
costs, they underestimate total costs related to
active maternal smoking. Further, the default
expenditure data are based on private sector
payment information, and hence do not repre-
sent expenses for other payers such as
Medicaid. Users should focus instead on the
SAFs generated by the software. Users should
apply the SAFs to the current expenditure data
for their population in an eVort to correct for
some of the limitations of the default expendi-
ture data and to generate estimates more
appropriate for their population. To enhance
further their use, standard errors for the SAFs
are presented in the software output.
Description of software
DESIGN FEATURES
SAMMEC 4.0 is a world wide web site version
of the earlier SAMMEC PC resident software.
The web site (http://www.medicost.com) is
accessible from any computer with a function-
ing internet connection and browser. The site
has been tested and is guaranteed to work with
Netscape Navigator 4.0, Microsoft Internet
Explorer 4.0, and more recent versions of these
products; it does not use any special features
that are not present in earlier versions of these
and other browsers. Given a connection and a
browser, the only additional requirement is a
valid user identification and password, which
will be supplied by CDC.
CALCULATION OF DISEASE IMPACT
The web site oVers health impact measures for
each of three population groups: adults (ages
18 years and over), neonates (newborns), and
children (ages 0–12 years). Health impact
measures for adults are based on their own
smoking history; those for neonates are based
on exposure of fetuses to maternal smoking
during pregnancy; and measures for children
are based on exposure to maternal smoking in
the home. Smoking attributable costs for ado-
lescents (ages 13–17 years) are excluded
because there are no data to support a simulta-
neous assessment of the impact of their own
smoking and that of exposure to parental
smoking. The four measures are smoking
attributable mortality, years of potential life
lost to smoking; indirect mortality costs, and
direct health care costs. The first three of these
measures were available in SAMMEC 3.0 and
were based on an attributable risk formula as
noted previously. The fourth measure, direct
health care costs, was based on an attributable
risk calculation in SAMMEC 2.0 and, as
noted, is absent in SAMMEC 3.0. In
SAMMEC 4.0, direct health care cost calcula-
tions are based on a series of new econometric
models.
The model used to derive direct health care
costs for neonates in MCHSAMMEC was
briefly described above. In addition, more spe-
cific information on this model and other
methodological issues underlying MCHSAM-
MEC estimates is included in the discussion
portion of the software. A discussion choice is
available to the user for each impact measure.
DATA INPUT
Calculation of the neonatal measures in the
MCHSAMMEC module allows the user to
specify certain input data. For the direct health
care costs, input data are limited to geographic
and other population subset specifications plus
an optional smoking prevalence override. For
example, a user may choose to calculate
estimates for a population of Medicaid
recipients 20–24 years old in a certain state.
Users also may input their own organisation’s
or state’s expenditure data instead of relying on
the estimates derived from the MarketScan©
database described above. For example, a
Medicaid user of MCHSAMMEC may want
to enter Medicaid expenditures.
In the absence of user supplied data, the web
site provides default values for all input data.
For the attributable risk-based measures, these
are the same data supplied as defaults by the
SAMMEC 3.0 software.
Users of SAMMEC 4.0 may store the
customised input data on their computers. The
“save to file” options allows the user to choose
the folders and filenames under which their
data are saved. The “retrieve” option can be
used to recall input data from previously saved
files.
Table 1 Sample neonatal health care cost smoking attributable fraction: MCHSAMMEC
module, SAMMEC Version 4.0
States selected:
Alabama and Missouri and North Carolina and Wyoming
Population demographic selected:
Age (years) < 18 or 18–34 or >34
Education No high school graduate or high school graduate, or some college or
college graduate
Insurance Private or Medicaid or other public or none
Marital status Married or unmarried
Prenatal care None or 1st trimester or 2nd trimester or 3rd trimester
Race White or African American or other
Descriptive statistics on selected subset of the standard population:
Observations: 241015 Number of observations matching selections above
Smoking prevalence: 16.43% Smoking prevalence in selected population
SA expenditures: $28.48 M Smoking attributable expenditures in selected
population
Total expenditures: $1.029 B Total expenditures in selected populations
SAF among smokers: 15.22% Smoking attributable fraction of expenditures for
smokers in selected population




prevalence: 30.0% Smoking prevalence in user’s population
User adjusted overall
SAF: 5.05% Smoking attributable fraction of expenditures adjusted
for user’s prevalence
Data are for illustration purposes only. M, million; B, billion.
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DATA OUTPUT
For each measure, SAMMEC 4.0 produces a
menu of report tables and, in some cases,
charts that may be accessed on screen and,
optionally, printed or saved to files on the
user’s computer. The attributable mortality
reports available in the MCHSAMMEC mod-
ule include tables detailing smoking preva-
lence, relative risk, mortality, and SAFs and
smoking attributable mortality. The neonatal
health care cost reports include the SAF table
(table 1) and the smoking attributable
expenditures table which provides both total
and smoking attributable expenditures.
Discussion
Although there have been numerous studies of
the increased risk of certain clinical outcomes
associated with smoking during pregnancy,6 7
only a few studies have tried to estimate some
of the costs related to smoking during
pregnancy. A recent issue of Morbidity and
Mortality Weekly Report provided the first
national estimates of pregnancy related costs
attributable to smoking.8
The MCHSAMMEC estimates may be used
in a number of ways to influence policy and
program initiatives. Estimates of health care
costs due to smoking during pregnancy are
informative to employers who self insure,
insurance companies, and managed care
organisations. The magnitude of these costs is
also important for public programs such as
Medicaid, which now covers a large proportion
of pregnant women and children. State Medic-
aid directors can use estimates of direct health
care costs and of cost savings associated with
smoking cessation to encourage increased cov-
erage of smoking cessation counselling for
pregnant women. They could also be used to
argue for directing tobacco settlement dollars
into the promotion and implementation of
smoking cessation programs for pregnant
women. Managed care entities may use
estimates of cost savings as they consider initi-
ating or expanding programs in prenatal smok-
ing cessation. It is also possible to use
MCHSAMMEC estimates to explore the rela-
tive cost eVectiveness of various interventions
and services oVered during the prenatal
period.
Users of the MCHSAMMEC estimates
should recognise the eVect of several
limitations. As noted, maternal costs, indirect
costs, and infant costs beyond the neonatal
period are not yet included. Without these
costs, MCHSAMMEC underestimates the
true costs associated with smoking during
pregnancy. EVorts are currently under way to
estimate infant costs beyond the costs of deliv-
ery as well as those occurring for children
exposed to smoke.
The relation between resource utilisation
and smoking behaviour, and hence the SAFs, is
based on 1995 data from PRAMS. Although
PRAMS includes questions on demographics,
health status, smoking history, obstetric
history, and pregnancy outcomes, it does not
include information on pregnancy and
childbirth costs. However, there are questions
about the length of stay, and whether the infant
was admitted to an NICU. In the absence of
cost data, these variables can serve as
reasonable proxies for resource utilisation and
cost.
Because MCHSAMMEC derives expendi-
ture estimates based on the 1996 Market
Scan© database, users must supply their own
expenditure data to obtain user specific dollar
estimates. Otherwise, given variations in insur-
ance service coverage and payment rates as
well as inflation over time, the dollar estimates
derived from the software will not reflect actual
costs for that user.
Summary
SAMMEC 4.0 and its MCHSAMMEC mod-
ule provide, for the first time, an opportunity
for state and other policy and program
directors to generate estimates of costs
attributable to smoking during pregnancy. The
software allows specification of various popula-
tions, subsets of populations, smoking
prevalence, and expenditure data while
maintaining default values for users who may
not have this information for their state or
organisation. Furthermore, MCHSAMMEC
allows users to compare their costs with costs
in other states or relevant populations. The
utility of MCHSAMMEC will be further
enhanced when infant costs beyond the costs
of delivery and maternal costs are included.
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